DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder

Charanraj Goud Alladi (1, 2, 3) , Bruno Etain (1, 2, 3, 4, 5, 6) , Frank Bellivier (1, 2, 3, 4, 5, 6) , Cynthia Marie-Claire (1, 2, 3)

1 VariaPsy - U1144 - Variabilité de réponse aux Psychotropes
2 UPD5 - Université Paris Descartes - Paris 5
3 USPC - Université Sorbonne Paris Cité
4 AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP)
5 Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris]
6 Fondation FondaMental [Créteil]

Domaines: Génomique, Transcriptomique et Protéomique [q-bio.GN]; Psychiatrie et santé mentale

Charanraj Goud Alladi, Bruno Etain, Frank Bellivier, Cynthia Marie-Claire. DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder. International Journal of Molecular Sciences, 2018, 19 (10), ⟨10.3390/ijms19103026⟩. ⟨hal-01904730⟩